BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1376745)

  • 1. Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells.
    Colombo MP; Lombardi L; Stoppacciaro A; Melani C; Parenza M; Bottazzi B; Parmiani G
    J Immunol; 1992 Jul; 149(1):113-9. PubMed ID: 1376745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different tumours, transduced with different cytokine genes as G-CSF and IL-2, show inhibition of tumour take through neutrophil activation but differ in T cell functions.
    Stoppacciaro A; Forni G; Colombo MP
    Folia Biol (Praha); 1994; 40(1-2):89-99. PubMed ID: 7525363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors.
    Colombo MP; Lombardi L; Melani C; Parenza M; Baroni C; Ruco L; Stoppacciaro A
    Am J Pathol; 1996 Feb; 148(2):473-83. PubMed ID: 8579110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo.
    Colombo MP; Ferrari G; Stoppacciaro A; Parenza M; Rodolfo M; Mavilio F; Parmiani G
    J Exp Med; 1991 Apr; 173(4):889-97. PubMed ID: 1706752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
    Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
    Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
    Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
    J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of T cell dependent acquired immunity in syngeneic mice by the combined expression of interleukin-4 and granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cells.
    Tasaki K; Gunji Y; Matsubara H; Takenaga K; Suzuki T; Asano T; Ochiai T; Isono K; Kouzu T; Sakiyama S; Tagawa M
    Anticancer Res; 1998; 18(3A):1453-6. PubMed ID: 9673355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
    Armstrong CA; Botella R; Galloway TH; Murray N; Kramp JM; Song IS; Ansel JC
    Cancer Res; 1996 May; 56(9):2191-8. PubMed ID: 8616871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
    Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T
    J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor-producing ascending colon cancer as indicated by histopathological findings: report of a case.
    Fujiwara Y; Yamazaki O; Takatsuka S; Kaizaki R; Inoue T
    Osaka City Med J; 2011 Dec; 57(2):79-84. PubMed ID: 22443081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
    Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
    Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
    Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
    Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.